Indication
ICU Sedation
3 clinical trials
3 products
Clinical trial
A Multi-center, Randomized, Single-blind, Parallel Controlled With Active Drug, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Remimazolam Tosilate for Injection for Sedation in the Intensive Care Unit (ICU)Status: Not yet recruiting, Estimated PCD: 2025-01-01
Product
RemimazolamProduct
PropofolClinical trial
Efficacy and Safety of Remimazolam Tosilate for Injection for Sedation in the Intensive Care Unit (ICU) - a Multicenter, Randomized, Single Blind, Dose Finding Phase II Clinical TrialStatus: Completed, Estimated PCD: 2023-04-02
Clinical trial
Evaluating the Efficacy and Safety of Remimazolam Tosilate for Injection for Prolonged Mechanical Ventilation Sedation in the Intensive Care Unit (ICU) - A Non-randomized, Multicenter, Single-arm, Open-label, Proof-of-concept, Phase I/II Clinical TrialStatus: Recruiting, Estimated PCD: 2023-11-01